1
|
Mbwasi R, Msovela K, Chilunda F, Tesha S, Canavan R, Wiedenmayer K. Comparing pharmacy practice in health facilities with and without pharmaceutically trained dispensers: a post intervention study in Tanzania. J Pharm Policy Pract 2024; 17:2323091. [PMID: 38572378 PMCID: PMC10989198 DOI: 10.1080/20523211.2024.2323091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/05/2024] Open
Abstract
Background The critical shortage of comprehensively trained healthcare staff in Tanzania affects the capacity to deliver essential health services, attain universal health coverage and compromises health outcomes. There is a specific lack of suitably trained pharmaceutical professionals, thus, an increase in the use of unqualified or poorly trained staff. Following the introduction of a one-year pharmacy dispenser course intervention, this study explored the impact that the new cadre of graduates had on pharmacy practice compared to healthcare facilities with non-pharmacy trained dispensers (NPTDs). Methods A post intervention assessment was conducted in 2021 using questionnaires formulated to measure indicators of Good Pharmacy Practice, comparing 29 public health facilities employing pharmacy-trained dispensers (PTD) with 32 public health facilities with NPTDs in Dodoma, Shinyanga and Morogoro regions of Tanzania. Data were collected by experienced pharmacists or pharmaceutical technicians and subsequently aggregated and statistically analysed. Results The dispensing times for medicines were found to be the same for PTDs and the NPTDs (2 min). There were no statistically significant differences in the adequacy of labelling elements between PTDs and NPTDs. Patients' level of knowledge of the medicines dispensed to them, from both PTDs and NPTDs, showed no difference. Moreover, no differences were observed in storage practice and documentation performance, records of dispensed medicines, handling of medicines and the dispensing area cleanliness between both groups. Overall, facilities with PTDs averaged a higher availability of tracer medicines (77%) than those with NPTDs (70%), however, availability of health commodities in all health facilities in the three regions was low and there was no statistically significant difference between both groups. Conclusion The study showed no significant difference in performance of pharmacy practice between PTDs and NPTDs despite the former undertaking a one-year training course intended to improve knowledge and skills. Practice application not only depends on effective training but on the working environment. Clear job descriptions, appropriate tools and references to guide, Standard Operating Procedures, acceptance by management of the training undertaken to actively encourage recruits to apply these new skills could improve PTDs performance. Training and knowledge alone do not seem to lead to better practice and performance.
Collapse
Affiliation(s)
- Romuald Mbwasi
- School of Pharmacy & Pharmaceutical Sciences, St John’s University of Tanzania, Dodoma, Tanzania
| | - Kelvin Msovela
- School of Pharmacy & Pharmaceutical Sciences, St John’s University of Tanzania, Dodoma, Tanzania
| | - Fiona Chilunda
- Health Promotion and System Strengthening (HPSS) Project, Dodoma
| | - Sia Tesha
- Health Promotion and System Strengthening (HPSS) Project, Dodoma
| | - Robert Canavan
- Swiss Tropical and Public Health Institute, Basel, Switzerland
- University of Basel, Basel, Switzerland
| | - Karin Wiedenmayer
- Swiss Tropical and Public Health Institute, Basel, Switzerland
- University of Basel, Basel, Switzerland
| |
Collapse
|
2
|
Samson NM, Sumari EI, Ndesendo V, Mbwasi R. Emergency contraceptive use of Metronidazole among University female students in Dodoma region of Tanzania: a descriptive cross-sectional study. Contracept Reprod Med 2023; 8:42. [PMID: 37608316 PMCID: PMC10464063 DOI: 10.1186/s40834-023-00241-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2023] [Accepted: 04/29/2023] [Indexed: 08/24/2023] Open
Abstract
BACKGROUND Metronidazole is known for its therapeutic effect as antibacterial and anti-parasitic. However, its toxicity on the reproductive system remains unclear. Metronidazole use in rodents is associates with toxic effects on the reproductive system, including hormonal alterations, reduced number of fertile cells and reduced sites for implantation, size of the placental disc area, constituent elements of the labyrinth, and spongiotrophoblast layers. Its use at a therapeutic dose among humans has been associated with an increased risk of spontaneous abortion. The effects on the reproductive system in humans may result in misconceptions about contraceptive effects hence sexually active individuals like students who, for any reason, fail to access safe contraceptive services use any possible methods to protect them from conception. This study aims to investigate the unofficial (un-prescribed) use of Metronidazole as an emergency contraceptive and some of its associated factors. METHODS This quantitative cross-sectional study involved 470 participants where stratified random sampling technique was used to obtain the sample from three educational institutions in the Dodoma Municipal, Dodoma region. Collected data were analyzed using SPSS version 25, descriptive statistical analysis was done to determine frequencies, percentages, and association, p < 0.05 was used to determine statistical significance. Further analysis using Multivariate binary logistic regression was done to determine the nature of the association between the study variables. RESULTS The finding shows that 169(62.4%) use Metronidazole as an emergency contraceptive. Notably, 345(73.4%) stated that they had ever heard someone use Metronidazole for contraception, especially their peers. Furthermore, an increase in the year of study was significantly associated with reduced use of Metronidazole as an emergency contraceptive (B = [-0.45], p = [0.02]). Furthermore, an increase in age, studying in non-medical college/university, the experience of using contraceptive methods, and hearing someone ever used Metronidazole was found to be positively associated with its use as an emergency contraceptive, although not statistically significant. CONCLUSION Metronidazole was found to be used as an emergency contraceptive in high doses, different factors associated with its use, and reasons influencing its use. Further research may be done to explore the toxicological effect of high doses of Metronidazole as a contraception and compare the efficiency of Metronidazole over other emergency contraceptives.
Collapse
Affiliation(s)
- Nipael M Samson
- Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, John's University of Tanzania, Formulation Sciences, and Pharmaceutical Services, Dodoma, Tanzania
| | - Emmanuel Izack Sumari
- Department of Nursing Management, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania.
| | - Valence Ndesendo
- Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, John's University of Tanzania, Formulation Sciences, and Pharmaceutical Services, Dodoma, Tanzania
| | - Romuald Mbwasi
- Department of Pharmaceutics, School of Pharmacy and Pharmaceutical Sciences, John's University of Tanzania, Formulation Sciences, and Pharmaceutical Services, Dodoma, Tanzania
| |
Collapse
|
3
|
Mbwasi R, Mbepera D, Mfuko W, Makanzo J, Kikwale M, Canavan R, Stoermer M, Wiedenmayer K. Assessing public–private procurement practices for medical commodities in Dar Es Salaam: a situation analysis. BMC Health Serv Res 2022; 22:1523. [PMCID: PMC9749154 DOI: 10.1186/s12913-022-08923-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Accepted: 12/05/2022] [Indexed: 12/16/2022] Open
Abstract
Background In Tanzania, the Medical Stores Department is the principal pharmaceutical provider to public health facilities throughout the country. However, growing demand from health facilities has proved difficult to satisfy and stock-outs at health facilities are frequent. The aim of the current study was to conduct a situation analysis of the procedures and practices of procuring medicines and medical supplies from private suppliers in the Dar es Salaam region when those commodities are unavailable at the Medical Stores Department. Methods A mixed-method approach including qualitative and quantitative methods was applied to understand procurement procedures and practices and private suppliers’ performance at district level. Qualitative interviews with suppliers and district authorities, and a review of inventory documents at store level was conducted between February and March 2018. The quantitative approach included a review and analyses of relevant procurement documents from the 2016/2017 financial year to explore the funds used to procure health commodities from the private sector. The ten most frequently mandated private suppliers were assessed in more detail focusing on cost, quality and availability of medicines and lead times and delivery. Results A lack of consistency and written guidelines for procuring medicines and medical supplies from the private sector was observed. The procurement process was bureaucratic and lengthy requiring multiple steps between health facilities, suppliers and district authorities. A significant number of people were involved requiring a minimum of 13 signatures and 16 steps from order preparation to approval. Only 17 of 77 prequalified private suppliers received orders from public health facilities. The criteria for choosing which supplier to use were unclear. Completed orders amounted to USD 663,491. The bureaucratic process drove councils and healthcare facilities towards alternative ways to procure health commodities when Medical Stores Department stock-outs occurred. Conclusion The procurement procedure outside the Medical Stores Department is inefficient and cumbersome, often circumventing government regulations. General lack of accountability renders the process susceptible to leakage of funds and medicines. Increasing the transparency and efficiency of procurement procedures from the private sector with a prime vendor system would help to better manage Medical Stores Department stock-outs and help improve health care services overall.
Collapse
Affiliation(s)
- Romuald Mbwasi
- grid.442456.50000 0004 0484 1130St. John’s University of Tanzania, Dodoma, Tanzania
| | - Denis Mbepera
- grid.415734.00000 0001 2185 2147Ministry of Health, Dodoma, Tanzania
| | - William Mfuko
- Senior freelance pharmaceutical consultant, Dar es Salaam, Tanzania
| | - Jason Makanzo
- Regional Administrative Secretary’s Office, Dar es Salaam, Tanzania
| | - Martha Kikwale
- grid.415734.00000 0001 2185 2147Ministry of Health, Dodoma, Tanzania
| | - Robert Canavan
- grid.416786.a0000 0004 0587 0574Swiss Tropical and Public Health Institute, P.O. Box, CH-4123 Allschwil, Switzerland ,grid.6612.30000 0004 1937 0642University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| | - Manfred Stoermer
- grid.416786.a0000 0004 0587 0574Swiss Tropical and Public Health Institute, P.O. Box, CH-4123 Allschwil, Switzerland ,grid.6612.30000 0004 1937 0642University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| | - Karin Wiedenmayer
- grid.416786.a0000 0004 0587 0574Swiss Tropical and Public Health Institute, P.O. Box, CH-4123 Allschwil, Switzerland ,grid.6612.30000 0004 1937 0642University of Basel, P.O. Box, CH-4003 Basel, Switzerland
| |
Collapse
|
4
|
Haroun Y, Sambaiga R, Sarkar N, Kapologwe NA, Kengia J, Liana J, Kimatta S, James J, Simon V, Hassan F, Mbwasi R, Fumbwe K, Litner R, Kahamba G, Dillip A. A human centred approach to digital technologies in health care delivery among mothers, children and adolescents. BMC Health Serv Res 2022; 22:1393. [PMID: 36419066 PMCID: PMC9682727 DOI: 10.1186/s12913-022-08744-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 09/19/2022] [Accepted: 10/14/2022] [Indexed: 11/25/2022] Open
Abstract
BACKGROUND Healthcare outcomes in child, adolescent and maternal in Tanzania are poor, and mostly characterised by fragmentary service provision. In order to address this weakness, digital technologies are sought to be integrated in the milieu of health as they present vast opportunities especially in the ability to improve health information management and coordination. Prior to the design and implementation of the Afya-Tek digital intervention, formative research was carried out to ensure that the solution meets the needs of the users. The formative research aimed to examine: the burden of disease and related health seeking behaviour; workflow procedures and challenges experiencing healthcare actors; adolescent health and health seeking behaviour; and lastly examine technological literacy and perceptions on the use of digital technologies in healthcare delivery. This paper therefore, presents findings from the formative research. METHODS The study employed exploratory design grounded in a qualitative approach. In-depth interview, focus group discussion, participant observation and documentary review methods were used for collecting data at different levels. The analysis was done thematically, whereby meaning was deduced behind the words which the participants used. RESULTS Findings suggest that the perceived burden of diseases and health seeking behaviour differ across age and social group. Multiple work-related challenges, such as lack of proper mechanism to track referrals and patient's information were noted across healthcare actors. There was a keen interest in the use of technologies shown by all study participants to improve care coordination and health outcomes among health system actors. Participants shared their views on how they envision the digital system working. CONCLUSION The formative research provided insightful background information with regard to the study objectives. The findings are used for informing the subsequent phases of the co-development and implementation of the Afya-Tek digital health intervention; with a view to making it relevant to the needs of those who will use it in the future. As such, the findings have to a large extent met the purpose of the current study by envisaging the best ways to design digital intervention tailored to meet the needs of those who will be using it.
Collapse
Affiliation(s)
- Yasini Haroun
- grid.8193.30000 0004 0648 0244Department of Sociology and Anthropology, University of Dar es Salaam, Dar es Salaam, Tanzania
| | - Richard Sambaiga
- grid.8193.30000 0004 0648 0244Department of Sociology and Anthropology, University of Dar es Salaam, Dar es Salaam, Tanzania
| | - Nandini Sarkar
- grid.11505.300000 0001 2153 5088Institute of Tropical Medicine, Antwerp, Belgium
| | - Ntuli A. Kapologwe
- Director of Health Services, The President’s Office-Regional Administration and Local Government (Po-RALG), Dodoma, Tanzania
| | - James Kengia
- The President’s Office-Regional Administration and Local Government (Po-RALG), Coordinator Regional Health Management Teams, Tanzania,, Tanzania
| | - Jafary Liana
- Apotheker Consultancy (T) Limited, Dar es Salaam, Tanzania
| | | | - Johanita James
- Apotheker Consultancy (T) Limited, Dar es Salaam, Tanzania
| | - Vendelin Simon
- grid.8193.30000 0004 0648 0244Department of Sociology and Anthropology, University of Dar es Salaam, Dar es Salaam, Tanzania
| | - Fatma Hassan
- Apotheker Consultancy (T) Limited, Dar es Salaam, Tanzania
| | - Romuald Mbwasi
- Apotheker Consultancy (T) Limited, Dar es Salaam, Tanzania
| | - Khadija Fumbwe
- Apotheker Consultancy (T) Limited, Dar es Salaam, Tanzania
| | | | | | - Angel Dillip
- Apotheker Consultancy (T) Limited, Dar es Salaam, Tanzania
| |
Collapse
|
5
|
Embrey M, Mbwasi R, Shekalaghe E, Liana J, Kimatta S, Ignace G, Dillip A, Hafner T. National Health Insurance Fund's relationship to retail drug outlets: a Tanzania case study. J Pharm Policy Pract 2021; 14:21. [PMID: 33593420 PMCID: PMC7888141 DOI: 10.1186/s40545-021-00303-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2020] [Accepted: 01/19/2021] [Indexed: 11/10/2022] Open
Abstract
Background Achieving universal health coverage will require robust private sector engagement; however, as many low- and middle-income countries launch prepayment schemes to achieve universal health coverage, few are covering products from retail drug outlets (pharmacies and drug shops). This case study aims to characterize barriers and facilitators related to incorporating retail drug outlets into national prepayment schemes based on the experience of the Tanzanian National Health Insurance Fund’s (NHIF) certification of pharmacies and accredited drug dispensing outlets. Methods We reviewed government documents and interviewed 26 key informants including retail outlet owners and dispensers and central and district government authorities representing eight districts overall. Topics included awareness of NHIF in the community, access to medicines, claims processing, reimbursement prices, and how the NHIF/retail outlet linkage could be improved. Results Important enablers for NHIF/retail outlet engagement include widespread awareness of NHIF in the community, NHIF’s straightforward certification process, and their reimbursement speed. All of the retail respondents felt that NHIF helps their business and their clients to some degree. As for barriers, retailers thought that NHIF needed to provide more information to them and to its members, particularly regarding coverage changes. Some retailers and government officials thought that the product reimbursement prices were below market and not adjusted often enough, and pharmacy respondents were unhappy about claim rejections for what they felt were insignificant issues. All interviewees agreed that one of the biggest problems is poor prescribing practices in public health facilities. They reiterated that prescribers need more supervision to improve their practices, particularly to ensure adherence to standard treatment guidelines, which NHIF requires for approving a claim. In addition, if a prescription has any problem, including a wrong date or no signature, the client must return to the health facility to get it corrected or pay out-of-pocket, which is burdensome. Conclusions Little published information is available on the relationship between health insurance plans and retail providers in low- and middle-income countries. This case study provides insights that countries can use when designing ways to include retail outlets in their health insurance schemes.
Collapse
Affiliation(s)
| | | | | | - Jafary Liana
- Apotheker Consultancy Co., Ltd, Dar es Salaam, Tanzania
| | | | | | - Angel Dillip
- Apotheker Consultancy Co., Ltd, Dar es Salaam, Tanzania
| | - Tamara Hafner
- Management Sciences for Health/Medicines, Technologies, and Pharmaceutical Services Program, Arlington, USA
| |
Collapse
|
6
|
Mbwasi R, Mapunjo S, Wittenauer R, Valimba R, Msovela K, Werth BJ, Khea AM, Nkiligi EA, Lusaya E, Stergachis A, Konduri N. National Consumption of Antimicrobials in Tanzania: 2017-2019. Front Pharmacol 2020; 11:585553. [PMID: 33192526 PMCID: PMC7662556 DOI: 10.3389/fphar.2020.585553] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2020] [Accepted: 09/24/2020] [Indexed: 01/13/2023] Open
Abstract
Objective: Surveillance of antimicrobial consumption is essential to the national action plan for antimicrobial resistance (AMR) as stipulated in the Global Action Plan on AMR and the Tanzanian National Action Plan on AMR. Given the paucity of antimicrobial consumption data in sub-Saharan Africa region, the objective of this study was to measure antimicrobial consumption in Tanzania. Methods: From 2017 to 2019, data on all antimicrobials imported into Tanzania were obtained from the Tanzania Medicines and Medical Devices Authority Data, augmented with purchasing data from the Medical Stores Department and data from local manufacturers. Data were collected and analyzed in accordance with the World Health Organization Anatomical Therapeutic Chemical and defined daily doses (DDD) methodology. Results: The average DDD per 1,000 inhabitants per day (DDD/1,000/D) for all antimicrobials was 80.8 ± 39.35. The DDD/1,000/D declined from 136.41 in 2017 to 54.98 in 2018 and 51.02 in 2019. Doxycycline, amoxicillin, and trimethoprim-sulfamethoxazole were the most frequently consumed antibiotics during these years, accounting for 20.01, 16.75, and 12.42 DDD/1,000/D, respectively. The majority of antimicrobial consumption in Tanzania occurred in the private sector, with the proportion of private-sector antibiotic consumption increasing annually from 2017 to 2019. Based on AWaRe classification >90% of antimicrobial consumption was Access class medications, with Watch and Reserve class medications accounting for <10% and <1%, respectively. Conclusion: The private sector use of antimicrobials is significantly increasing and should be carefully monitored in accordance with national policies. Future work is necessary to increase reporting of antimicrobial consumption patterns in sub-Saharan Africa.
Collapse
Affiliation(s)
| | - Siana Mapunjo
- Ministry of Health, Community Development, Gender, Elderly, and Children, Dodoma, Tanzania
| | - Rachel Wittenauer
- Department of Global Health, School of Public Health, University of Washington, Seattle, WA, United States
| | - Richard Valimba
- USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Dar es Salaam, Tanzania
| | | | - Brian J Werth
- Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, United States
| | | | | | - Edgar Lusaya
- USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Dar es Salaam, Tanzania
| | - Andy Stergachis
- Department of Global Health, School of Public Health, University of Washington, Seattle, WA, United States.,Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, WA, United States
| | - Niranjan Konduri
- USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, United States
| |
Collapse
|
7
|
Wiedenmayer K, Mbwasi R, Mfuko W, Mpuya E, Charles J, Chilunda F, Mbepera D, Kapologwe N. Jazia prime vendor system- a public-private partnership to improve medicine availability in Tanzania: from pilot to scale. J Pharm Policy Pract 2019; 12:4. [PMID: 30891247 PMCID: PMC6388475 DOI: 10.1186/s40545-019-0163-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2018] [Accepted: 01/10/2019] [Indexed: 11/23/2022] Open
Abstract
Background The availability of medicines in public health facilities in Tanzania is problematic. Medicines shortages are often caused by unavailability at Medical Stores Department, the national supplier for public health facilities. During such stock-outs, districts may purchase from private suppliers. However, this procedure is intransparent, bureaucratic and uneconomic. Objectives To complement the national supply chain in case of stock-outs with a simplified, transparent and efficient procurement procedure based on a public-private partnership approach with a prime vendor at the regional level. To develop a successful pilot of a Prime Vendor system with the potential for national scale-up. Methods A public-private partnership was established engaging one private sector pharmaceutical supplier as the Prime Vendor to provide the complementary medicines needed by public health facilities in Tanzania. The Dodoma pilot region endorsed the concept involving the private sector, and procedures to procure complementary supplies from a single vendor in a pooled regional contract were developed. A supplier was tendered and contracted based on Good Procurement Practice. Pilot implementation was guided by Standard Operating Procedures, and closely monitored with performance indicators. A 12-step approach for national implementation was applied including cascade training from national to facility level. Each selected vendor signed a contract with the respective regional authority. Results In the pilot region, tracer medicines availability increased from 69% in 2014 to 94% in 2018. Prime vendor supplies are of assured quality and average prices are comparable to prices of Medical Stores Department. Procurement procedures are simplified, shortened, standardized, transparent and well-governed. Procurement capacity was enhanced at all levels of the health system. Proven successful, the Prime Vendor system pilot was rolled-out nationally, on government request, to all 26 regions of mainland Tanzania, covering 185 councils and 5381 health facilities. Conclusion The Prime Vendor system complements regular government supply through a regional contract approach. It is anchored in the structures of the regional health administration and in the decentralisation policy of the country. This partnership with the private sector facilitates procurement of additional supplies within a culture of transparency and accountability. Regional leadership, convincing pilot results and policy dialogue have led to national roll-out. Transferring this smaller-scale supply chain intervention to other regions requires country ownership and support for sustainable operations.
Collapse
Affiliation(s)
- Karin Wiedenmayer
- 1Swiss Tropical and Public Health Institute, Basel, Switzerland.,2University of Basel, Petersplatz 1, 4051 Basel, Switzerland
| | - Romuald Mbwasi
- 3Senior pharmaceutical consultant, Dar es Salaam and senior lecturer at St. John's University of Tanzania, Dodoma, Tanzania
| | - William Mfuko
- Senior pharmaceutical consultant, Dar es Salaam, Dodoma, Tanzania
| | - Ezekiel Mpuya
- Health System Resource Center, President's Office Regional Administration and Local Government, Dodoma, Tanzania
| | - James Charles
- Regional Medical Officer, Regional Administrative Secretary's Office, Dodoma, Tanzania
| | - Fiona Chilunda
- Health Promotion and System Strengthening Project, Dodoma, Tanzania
| | - Denis Mbepera
- Regional Pharmacist, Regional Administrative Secretary's Office, Dodoma, Tanzania
| | - Ntuli Kapologwe
- Director of Health Services, Social Welfare and Nutrition Services, President's Office of Regional Administration and Local Government, Dodoma, Tanzania
| |
Collapse
|
8
|
Chalker JC, Vialle-Valentin C, Liana J, Mbwasi R, Semali IA, Kihiyo B, Shekalaghe E, Dillip A, Kimatta S, Valimba R, Embrey M, Lieber R, Rutta E, Johnson K, Ross-Degnan D. What roles do accredited drug dispensing outlets in Tanzania play in facilitating access to antimicrobials? Results of a multi-method analysis. Antimicrob Resist Infect Control 2015; 4:33. [PMID: 26301089 PMCID: PMC4545914 DOI: 10.1186/s13756-015-0075-2] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/27/2015] [Accepted: 08/14/2015] [Indexed: 11/27/2022] Open
Abstract
Background People in low-income countries purchase a high proportion of antimicrobials from retail drug shops, both with and without a prescription. Tanzania’s accredited drug dispensing outlet (ADDO) program includes dispenser training, enforcement of standards, and the legal right to sell selected antimicrobials. We assessed the role of ADDOs in facilitating access to antimicrobials. Methods We purposively chose four regions, randomly selected three districts and five wards per district. Study methods included interviews at 1200 households regarding care-seeking for acute illness and knowledge about antimicrobials; mystery shoppers visiting 306 ADDOs posing as a caregiver of a child with 1) pneumonia, 2) mild acute respiratory infection (ARI), or 3) a runny nose and request for co-trimoxazole; and audits of antimicrobial availability and prices at 84 public health facilities (PHFs) and 96 ADDOs. Results Four hundred sixty seven (76 %) members from 367 (77 %) households had recently sought care outside the home for acute illness; 128 had purchased antimicrobials, of which 61 % had been recommended by a doctor or nurse and 32 % by an ADDO dispenser. Only 29 % obtained the antimicrobial at a PHF, whereas, 48 % purchased them at an ADDO. Most thought that ADDOs are convenient place for care, usually have needed medicines, and have high quality services and products, contrasting with 66 % who reported dissatisfaction with PHF waiting times and 56 % with medicine availability. One-third (34 %) of mystery shoppers presenting the mild ARI scenario were inappropriately sold an antimicrobial and 85 % were sold one on request; encouragingly, 99 % presenting a case of pneumonia received either an antimicrobial, referral to a trained provider, or request to bring the child for examination. Overall, 63 and 60 % of the 15 tracer antimicrobials were in stock in ADDOs and PHFs, respectively; ADDOs had significantly more antimicrobial formulations for children available (83 vs. 51 %). Of 369 records of antimicrobial sales in 47 ADDOs, 63 % were dispensed on prescription. Conclusion ADDOs have increased access to antimicrobials in Tanzania. Community members see them as integral to the health system. Antimicrobials are overused due to poor ADDO dispensing, poor PHF prescribing, and inappropriate public demand. Multi-pronged interventions are needed to address all determinants. Electronic supplementary material The online version of this article (doi:10.1186/s13756-015-0075-2) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- John C Chalker
- Center for Pharmaceutical Management, Management Science for Health, 4301 North Fairfax Drive, Arlington, VA 22203 USA
| | - Catherine Vialle-Valentin
- Drug Policy Research Group, Department of Population Medicine, Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215 USA
| | - Jafary Liana
- Management Science for Health, Dar es Salam, Tanzania
| | - Romuald Mbwasi
- Apotheker Consultancy (T) Ltd;, St. Johns University of Dodoma, Dodoma, Tanzania
| | - Innocent A Semali
- Muhimbili University of Health and Allied Sciences, P.O. Box 65015, Dar es Salaam, Tanzania
| | - Bernard Kihiyo
- Tanzania Consumer Advocacy Society (TCAS), Dar es Salaam, Tanzania
| | | | - Angel Dillip
- Ifakara Health Institute, Plot 463, Kiko Avenue Mikocheni, P.O. Box 78 373, Dar es Salaam, Tanzania
| | | | | | - Martha Embrey
- Center for Pharmaceutical Management, Management Science for Health, 4301 North Fairfax Drive, Arlington, VA 22203 USA
| | - Rachel Lieber
- Center for Pharmaceutical Management, Management Science for Health, 4301 North Fairfax Drive, Arlington, VA 22203 USA
| | - Edmund Rutta
- Center for Pharmaceutical Management, Management Science for Health, 4301 North Fairfax Drive, Arlington, VA 22203 USA
| | - Keith Johnson
- Center for Pharmaceutical Management, Management Science for Health, 4301 North Fairfax Drive, Arlington, VA 22203 USA
| | - Dennis Ross-Degnan
- Drug Policy Research Group, Department of Population Medicine, Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, 6th Floor, Boston, MA 02215 USA
| |
Collapse
|
9
|
Rutta E, Kibassa B, McKinnon B, Liana J, Mbwasi R, Mlaki W, Embrey M, Gabra M, Shekalaghe E, Kimatta S, Sillo H. Increasing Access to Subsidized Artemisinin-based Combination Therapy through Accredited Drug Dispensing Outlets in Tanzania. Health Res Policy Syst 2011; 9:22. [PMID: 21658259 PMCID: PMC3141785 DOI: 10.1186/1478-4505-9-22] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/20/2010] [Accepted: 06/09/2011] [Indexed: 11/21/2022] Open
Abstract
BACKGROUND In Tanzania, many people seek malaria treatment from retail drug sellers. The National Malaria Control Program identified the accredited drug dispensing outlet (ADDO) program as a private sector mechanism to supplement the distribution of subsidized artemisinin-based combination therapies (ACTs) from public facilities and increase access to the first-line antimalarial in rural and underserved areas. The ADDO program strengthens private sector pharmaceutical services by improving regulatory and supervisory support, dispenser training, and record keeping practices. METHODS The government's pilot program made subsidized ACTs available through ADDOs in 10 districts in the Morogoro and Ruvuma regions, covering about 2.9 million people. The program established a supply of subsidized ACTs, created a price system with a cost recovery plan, developed a plan to distribute the subsidized products to the ADDOs, trained dispensers, and strengthened the adverse drug reactions reporting system. As part of the evaluation, 448 ADDO dispensers brought their records to central locations for analysis, representing nearly 70% of ADDOs operating in the two regions. ADDO drug register data were available from July 2007-June 2008 for Morogoro and from July 2007-September 2008 for Ruvuma. This intervention was implemented from 2007-2008. RESULTS During the pilot, over 300,000 people received treatment for malaria at the 448 ADDOs. The percentage of ADDOs that dispensed at least one course of ACT rose from 26.2% during July-September 2007 to 72.6% during April-June 2008. The number of malaria patients treated with ACTs gradually increased after the start of the pilot, while the use of non-ACT antimalarials declined; ACTs went from 3% of all antimalarials sold in July 2007 to 26% in June 2008. District-specific data showed substantial variation among the districts in ACT uptake through ADDOs, ranging from ACTs representing 10% of all antimalarial sales in Kilombero to 47% in Morogoro Rural. CONCLUSIONS The intervention increased access to affordable ACTs for underserved populations. Indications are that antimalarial monotherapies are being "crowded out" of the market. Importantly, the transition to ACTs has been accomplished in an environment where the safety and efficacy of the drugs and the quality of services are being monitored and regulated. This paper presents a description of the pilot program implementation, results of the program evaluation, and a discussion of the challenges and recommendations that will be used to guide rollout of subsidized ACT in ADDOs in the rest of Tanzania and possibly in other countries.
Collapse
Affiliation(s)
- Edmund Rutta
- Management Sciences for Health, Center for Pharmaceutical Services, Arlington, USA
| | | | - Brittany McKinnon
- McGill University, Department of Epidemiology, Biostatics' and Occupational Health, Montreal, Canada
| | - Jafary Liana
- Management Sciences for Health, Center for Pharmaceutical Services, Dar es Salaam, Tanzania
| | - Romuald Mbwasi
- Management Sciences for Health, Center for Pharmaceutical Services, Dar es Salaam, Tanzania
| | - Wilson Mlaki
- Management Sciences for Health, Center for Pharmaceutical Services, Dar es Salaam, Tanzania
| | - Martha Embrey
- Management Sciences for Health, Center for Pharmaceutical Services, Arlington, USA
| | - Michael Gabra
- Management Sciences for Health, Center for Pharmaceutical Services, Dar es Salaam, Tanzania
| | | | - Suleiman Kimatta
- Management Sciences for Health, Center for Pharmaceutical Services, Dar es Salaam, Tanzania
| | - Hiiti Sillo
- Tannzania Food and Drug Authority, Dar es Salaam, Tanzania
| |
Collapse
|
10
|
Rutta E, Senauer K, Johnson K, Adeya G, Mbwasi R, Liana J, Kimatta S, Sigonda M, Alphonce E. Creating a new class of pharmaceutical services provider for underserved areas: the Tanzania accredited drug dispensing outlet experience. Prog Community Health Partnersh 2011; 3:145-53. [PMID: 20208262 DOI: 10.1353/cpr.0.0063] [Citation(s) in RCA: 38] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
THE PROBLEM In developing countries, the most accessible source of treatment for common conditions is often an informal drug shop, where drug sellers are untrained and operations are unmonitored. PURPOSE We sought to describe a public-private initiative in Tanzania that created a new class of provider in government-accredited drug outlets, which improved the quality of medicines and pharmaceutical services in previously underserved areas. KEY POINTS The accredited drug-dispensing outlet program combines changing behavior and expectations of community members who use, own, regulate, and work in drug shops. Success resulted from including community stakeholders from the beginning of the process. CONCLUSIONS Addressing shortages in qualified health care providers by training and accrediting private sector drug dispensers to recognize common conditions and provide quality pharmaceutical products and services is feasible in a developing country, when supported by an appropriate policy and regulatory environment. Scaling up and sustaining the program will be a challenge.
Collapse
Affiliation(s)
- Edmund Rutta
- Center for Pharmaceutical Management, Management Sciences for Health, MA, USA
| | | | | | | | | | | | | | | | | |
Collapse
|
11
|
|